Trial Profile
Escitalopram in Greek patients with major depressive disorder with or without a concomitant neurological disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2014
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Jan 2014 New trial record